How are COVID-19 vaccines being developed?

Aswin Seshasayee, NCBS-TIFR;  Mohak Sharda, NCBS-TIFR, Archit Sharda, Srishti School of Design

The novel coronavirus-2 uses one of its proteins to bind to a molecular receptor on human cells. This interaction is critical to successful infection. The human immune system produces “antibodies” in response to infections. Antibodies naturally produced by our immune system against the novel coronavirus reduce the interaction of the virus with its human receptor. This provides ideas and candidates for drug as well as vaccine development.

[Last update 05 April 2020]